{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:45:09Z","timestamp":1786221909898,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jmii.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T06:52:42Z","timestamp":1786171962000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes in patients hospitalized for COVID-19 in the periods of non-Omicron and Omicron variant dominance"],"prefix":"10.1016","author":[{"given":"Yi-Jhen","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-I","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7058-6244","authenticated-orcid":false,"given":"Ko-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen Chung-Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horng-Chyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2026.07.010_bib1","unstructured":"Prevention CfDCa. COVID data tracker. Centers for Disease Control and Prevention. Accessed April 17, 2025. https:\/\/covid.cdc.gov\/covid-data-tracker."},{"issue":"13","key":"10.1016\/j.jmii.2026.07.010_bib2","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.7150\/ijms.76725","article-title":"Comparison of clinical characteristics and outcomes of hospitalized patients infected with the D614G strain or alpha variant of COVID-19 in Taiwan: a multi-center cohort study","volume":"19","author":"Huang","year":"2022","journal-title":"Int J Med Sci"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.010_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bj.2022.11.002","article-title":"Clinical and laboratory predictors for disease progression in patients with COVID-19: a multi-center cohort study","volume":"46","author":"Lin","year":"2023","journal-title":"Biomed J"},{"key":"10.1016\/j.jmii.2026.07.010_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2147\/IDR.S479896","article-title":"Comparison of clinical characteristics and mortality outcome in critical COVID-19 patients infected with alpha and Omicron variants","volume":"18","author":"Cheng","year":"2025","journal-title":"Infect Drug Resist"},{"issue":"13","key":"10.1016\/j.jmii.2026.07.010_bib5","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.7150\/ijms.76725","article-title":"Comparison of clinical characteristics and outcomes of hospitalized patients infected with the D614G strain or alpha variant of COVID-19 in Taiwan: a multi-center cohort study. Research paper","volume":"19","author":"Huang","year":"2022","journal-title":"Int J Med Sci"},{"issue":"Suppl 1","key":"10.1016\/j.jmii.2026.07.010_bib6","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jfma.2023.08.016","article-title":"COVID-19 public health surveillance and response in Taiwan: from containment to mitigation","volume":"123","author":"Chen","year":"2024","journal-title":"J Formos Med Assoc"},{"issue":"10332","key":"10.1016\/j.jmii.2026.07.010_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.010_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-98834-y","article-title":"Deaths \"due to\" COVID-19 and deaths \"with\" COVID-19 during the Omicron variant surge, among hospitalized patients in seven tertiary-care hospitals, Athens, Greece","volume":"15","author":"Basoulis","year":"2025","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.jmii.2026.07.010_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185904","article-title":"Patients hospitalized for COVID-19 in the periods of Delta and Omicron variant dominance in Greece: determinants of severity and mortality","volume":"12","author":"Karageorgou","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.010_bib11","article-title":"Comparison of clinical characteristics and outcomes of critically ill adults with SARS-CoV-2 infection during Delta and Omicron variant predominance periods: a single-hospital retrospective cohort study","volume":"10","author":"Sankar","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jmii.2026.07.010_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958418","article-title":"Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period","volume":"13","author":"Sonaglioni","year":"2022","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.jmii.2026.07.010_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chron Dis"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.010_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"issue":"6","key":"10.1016\/j.jmii.2026.07.010_bib15","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.dsx.2020.10.022","article-title":"Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis","volume":"14","author":"Tuty Kuswardhani","year":"2020","journal-title":"Diabetes Metabol Syndr"},{"issue":"2","key":"10.1016\/j.jmii.2026.07.010_bib16","first-page":"117","article-title":"Does the Charlson comorbidity index help predict the risk of death in COVID-19 patients?","volume":"9","author":"Comoglu","year":"2022","journal-title":"North Clin Istanb"},{"issue":"10239","key":"10.1016\/j.jmii.2026.07.010_bib17","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York city: a prospective cohort study","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.jmii.2026.07.010_bib18","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jmii.2026.07.010_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.jmii.2026.07.010_bib20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"Li","year":"2020","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118226000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T20:29:57Z","timestamp":1786220997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118226000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":19,"alternative-id":["S1684118226000964"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2026.07.010","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes in patients hospitalized for COVID-19 in the periods of non-Omicron and Omicron variant dominance","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}